Oxford Nanopore Technologies Plc ONT

Financing co-led by Heal Capital and Ananda Impact Ventures will advance the Aitios® platform and ongoing validation of lead program to identify preeclampsia risk in a pregnancy’s first trimesterDr. Gordon Sanghera CBE FRS, co-founder and former CEO of Oxford Nanopore Technologies, joins Aitiologic’s advisory board and participates in the round as an investorDr. Rebecca Ertl, obstetrician-gynecologist and founder of a leading prenatal diagnostics center, appointed Chief Medical Officer VIENNA, S

The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker development, single-cell and spatial transcriptomics, long-read RNA sequencing, and AI-powered analytics. Consumables, bulk RNA-seq, drug discovery applications, and pharmaceutical and biotechnology companies led the market in 2025. North America held the largest regional share

Oxford Nanopore Technologies (LON:ONT) reported first-half revenue growth below its expectations as declines in China, the Middle East and delayed orders in the Americas weighed on performance, while gross-margin expansion and lower operating expenses narrowed its adjusted EBITDA loss. Revenue for

Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has upgraded its Pitfield project in Western Australia to 8.16 billion tonnes, confirming it as the world's largest titanium resource. That includes a first Measured Resource of 374 million tonnes at a solid 5.8% grade. Vast Resources PLC (LSE:VAST, FRA:D9A) has completed its takeover of Gulf International Minerals, adding a producing gold and silver mine in Tajikistan. It's also raised around £7.5 million to fund the next stage of development following its re-admission to London's AIM. Rockfire Resources PLC (LSE:ROCK) has hit fresh high-grade zinc and

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approximately USD 6.8 Billion in 2025 and is expected to reach USD 8.3 Billion in 2026 and is expected to reach around USD 56.1 Billion by 2035, at a CAGR of 23.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc.,

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Targeted DNA RNA Sequencing Market size & share revenue was valued at approximately USD 8.6 Billion in 2025 and is expected to reach USD 10.2 Billion in 2026 and is expected to reach around USD 46.9 Billion by 2035, at a CAGR of 18.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina, F. Hoffman-L

Agilent Technologies (NYSE:A) highlighted new technologies and scientific data aimed at advancing cancer research. The company presented these developments at the American Association for Cancer Research Annual Meeting. Agilent also announced a scientific collaboration with Oxford Nanopore Technologies focused on oncology research tools. For investors, Agilent Technologies sits at the intersection of instruments, diagnostics, and life sciences tools, an area that underpins much of modern...

Earlier this week, Cepheid, a Danaher company, and Oxford Nanopore Technologies expanded their partnership to develop faster, more comprehensive molecular workflows for identifying bacterial and fungal pathogens, antimicrobial resistance, and genomic antibiotic susceptibility in bloodstream infection and sepsis research. This move deepens Danaher’s involvement in complex infectious disease diagnostics, potentially reinforcing its position in high-value, research-oriented testing as...

Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, today announced an expansion of their partnership to develop a workflow for rapid bacterial and fungal pathogen identification. Following a successful phase one collaboration announced at the European Society of Clinical Microbiology and Infectious Diseases

Optical Genome Mapping Market Optical Genome Mapping Market Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market Report 2026" has been added to ResearchAndMarkets.com's offering. The market's potential is comprehensively covered in recent reports, offering detailed insights into market size, regional shares, competitor landscape, trends, and opportunities. The optical genome mapping market is poised for substantial growth, expanding from $0.23 billion in 2025 to $0.29 bi

Insiders were net buyers of Oxford Nanopore Technologies plc's ( LON:ONT ) stock during the past year. That is...

Oxford Nanopore Technologies (LON:ONT) used its FY 2025 results call to outline a leadership transition, review a year of growth and cost control, and provide guidance for 2026 alongside commentary on strategic focus and product portfolio changes. Leadership transition and company positioning The c

Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis speed and accuracy Whole Genome Sequencing Market Whole Genome Sequencing Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's offering. The Global Whole Genome Sequencing Market is projected to expand from USD 2.18 Billion